Blood mRNA and miRNA transcriptome to predict chronic lung allograft dysfunction

Pierre-Joseph Royer (Nantes, France), Pierre-Joseph Royer, Daniel Baron, Damien Reboulleau, Adrien Tissot, Karine Botturi-Cavailles, Antoine Roux, Martine Reynaud-Gaubert, Romain Kessler, Sacha Mussot, Claire Dromer, Olivier Brugière, Jean-Francois Mornex, Romain Guillemain, Marcel Dahan, Christiane Knoop, Christophe Pison, Angela Koutsokera, Laurent Nicod, Sophie Brouard, Antoine Magnan

Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Session: Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Session type: Poster Discussion
Number: 1792

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Pierre-Joseph Royer (Nantes, France), Pierre-Joseph Royer, Daniel Baron, Damien Reboulleau, Adrien Tissot, Karine Botturi-Cavailles, Antoine Roux, Martine Reynaud-Gaubert, Romain Kessler, Sacha Mussot, Claire Dromer, Olivier Brugière, Jean-Francois Mornex, Romain Guillemain, Marcel Dahan, Christiane Knoop, Christophe Pison, Angela Koutsokera, Laurent Nicod, Sophie Brouard, Antoine Magnan. Blood mRNA and miRNA transcriptome to predict chronic lung allograft dysfunction. Eur Respir J 2015; 46: Suppl. 59, 1792

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A new biomarker for chronic lung allograft dysfunction
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014

Serum cytokines patterns in lung transplant recipients
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015


Pulmonary function and respiratory complications in hematopoietic cell transplant
Source: International Congress 2016 – Quality and quantity in lung function
Year: 2016


An immunohistochemical study to evaluate the presence of B-cells in chronic lung allograft dysfunction
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014


Prostacyclin and VEGF in the rejection process after lung transplantation – A possible biomarker
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2018 – Rare lung diseases
Year: 2018


Regional specific gas volume as an early marker of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2016 – Lung function and imaging: new findings and new approaches
Year: 2016

Altered extracellular matrix in transplanted lungs as a potential marker for chronic rejection
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Risk factors for chronic lung allograft dysfunction (CLAD) in the SysCLAD cohort
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015

Integrated mRNA and miRNA expression profiling of long-term survivors with normal allograft function after lung transplantation
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019

Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease
Year: 2016


Orthotopic lung transplantation in a single-mismatch-based mouse model shows signs of chronic lung allograft dyfunction (CLAD)
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Elevated levels of prostacyclin and VEGF in the rejection process after lung transplantation
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013

Lung volumes predict survival in patients with chronic lung allograft dysfunction
Source: Eur Respir J , 49 (4)  1601315; DOI: 10.1183/13993003.01315-2016
Year: 2017



Pirfenidone stabilizes pulmonary function and reduces 18F-FDG-uptake in restrictive allograft syndrome following lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014

Inflammatory response following DCD and DBD lung transplantation
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016


Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD)
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017

Clinical course of patients with bronchiolitis obliterans after hematopoietic stem cell transplantation
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014


Chronic lung damage by repetitive instillation of gastric fluid in a rat model: Histological and functional changes
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013

A model of chronic lung allograft rejection in the rat
Source: Eur Respir J 2010; 35: 1354-1363
Year: 2010